Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1929852A enables scalable α-PGG production without chromatography. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN111689883B reveals a novel copper-catalyzed route for diaryl sulfones. This method offers mild conditions, air oxidation, and significant cost reduction potential.
Novel CaC2/TEA method improves yield to 78%. Green, mild conditions for API intermediates. Cost-effective supply chain solution for pharmaceutical manufacturing.
Patent CN113976141B reveals catalytic conversion of IDPN waste to high-purity beta-aminopropionitrile, offering significant cost reduction and enhanced supply chain stability for manufacturers.
Patent CN112312902B enables direct enantioselective C-H arylation of free carboxylic acids. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN115073399A reveals a low-cost bifunctional catalyst for high-yield chiral beta-butyrolactone production, offering significant supply chain advantages.
Patent CN102174006A details a novel chiral hydroxyl amide synthesis using copper acetate, offering high conversion rates for pharmaceutical intermediate manufacturing.
Novel Ru-phosphine-nitrogen complexes enable efficient ketone reduction. Enhances supply chain reliability and reduces manufacturing costs for chiral intermediates.
Patent CN112279743B details a novel iridium-catalyzed asymmetric hydrogenation method for chiral alpha-amino acid esters, offering high enantioselectivity and industrial scalability for pharmaceutical intermediates.
Patent CN102397793A reveals efficient cinchona-squaramide catalysts for asymmetric reactions, offering scalable synthesis and superior stereoselectivity for pharma intermediates.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Patent CN115477663A details a safe, high-yield route for [IPr-BH2-NH3]I. This breakthrough offers cost-effective manufacturing and reliable supply for catalytic applications.
Novel binaphthyl-based phase transfer catalyst offering high enantioselectivity up to 98% ee. Ideal for pharmaceutical intermediates manufacturing with scalable processes.
Patent CN108238948B reveals a catalyst-free oxidation route for alpha-o-nitrobenzene ethanol, offering high purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN116803505B reveals high-efficiency Pt-ZrO2 catalyst for carbazole. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Patent CN102408339A introduces a recyclable heteropolyacid pyridinium ionic liquid for clean nitration, offering significant cost reduction and environmental benefits for fine chemical manufacturing.
Patent CN103694167A details a high-yield synthesis of Flunixin Meglumine using a novel CuO/TsOH dual-catalyst system in water, offering significant cost and purity advantages for veterinary pharmaceutical manufacturers.
Patent CN103193654A reveals a high-yield metalloporphyrin catalytic oxidation process for o-nitrobenzoic acid, offering significant cost reduction and supply chain efficiency for pharmaceutical intermediates.
Patent CN103087105B details high-efficiency asymmetric hydrogenation for chiral beta-aryl amides, offering significant supply chain and cost advantages for pharmaceutical manufacturing.